<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>buPROPion</title><link>http://www.unboundmedicine.com/medline/ebm/research/buPROPion</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926400/full_citation/An_open_label_study_of_naltrexone_and_bupropion_combination_therapy_for_smoking_cessation_in_overweight_and_obese_subjects_</link><description>Wilcox CS, Oskooilar N, Erickson JS, et al. <br/><span class="title">An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects. [JOURNAL ARTICLE]</span><br/><span class="source" title="Addictive behaviors">Addict Behav 2009 Oct 31.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926400/abstract/An_open_label_study_of_naltrexone_and_bupropion_combination_therapy_for_smoking_cessation_in_overweight_and_obese_subjects_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926400/full_citation/An_open_label_study_of_naltrexone_and_bupropion_combination_therapy_for_smoking_cessation_in_overweight_and_obese_subjects_">Full Citation</a></description></item><item><title>The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922576/full_citation/The_cost_effectiveness_of_antidepressants_for_smoking_cessation_in_chronic_obstructive_pulmonary_disease__COPD__patients_</link><description>Van Schayck CP, Kaper J, Wagena EJ, et al. <br/><span class="title">The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Addiction (Abingdon, England)">Addiction 2009 Dec; 104(12):2110-2117.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922576/abstract/The_cost_effectiveness_of_antidepressants_for_smoking_cessation_in_chronic_obstructive_pulmonary_disease__COPD__patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922576/full_citation/The_cost_effectiveness_of_antidepressants_for_smoking_cessation_in_chronic_obstructive_pulmonary_disease__COPD__patients_">Full Citation</a></description></item><item><title>Acute effects of pharmacotherapies in blood pressure in normotensive moderate smokers.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19919396/full_citation/Acute_effects_of_pharmacotherapies_in_blood_pressure_in_normotensive_moderate_smokers_</link><description>Martins LC, Ferreira-Melo SE, Sabha M, et al. <br/><span class="title">Acute effects of pharmacotherapies in blood pressure in normotensive moderate smokers. [JOURNAL ARTICLE]</span><br/><span class="source" title="Blood pressure">Blood Press 2009 Oct 29; 18(5):255-260.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19919396/abstract/Acute_effects_of_pharmacotherapies_in_blood_pressure_in_normotensive_moderate_smokers_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19919396/full_citation/Acute_effects_of_pharmacotherapies_in_blood_pressure_in_normotensive_moderate_smokers_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19919396/Acute_effects_of_pharmacotherapies_in_blood_pressure_in_normotensive_moderate_smokers_">Find Related Articles</a> </description></item><item><title>Evidence for dopamine involvement in ambulation promoted by pulegone in mice.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917306/full_citation/Evidence_for_dopamine_involvement_in_ambulation_promoted_by_pulegone_in_mice_</link><description>Umezu T <br/><span class="title">Evidence for dopamine involvement in ambulation promoted by pulegone in mice. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pharmacology, biochemistry, and behavior">Pharmacol Biochem Behav 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917306/abstract/Evidence_for_dopamine_involvement_in_ambulation_promoted_by_pulegone_in_mice_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917306/full_citation/Evidence_for_dopamine_involvement_in_ambulation_promoted_by_pulegone_in_mice_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19917306/Evidence_for_dopamine_involvement_in_ambulation_promoted_by_pulegone_in_mice_">Find Related Articles</a> </description></item><item><title>The Cost-Effectiveness of an Extended Course (12 + 12 Weeks) of Varenicline Compared with Other Available Smoking Cessation Strategies in the United States: An Extension and Update to the BENESCO Model.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19912599/full_citation/The_Cost_Effectiveness_of_an_Extended_Course__12_+_12_Weeks__of_Varenicline_Compared_with_Other_Available_Smoking_Cessation_Strategies_in_the_United_States:_An_Extension_and_Update_to_the_BENESCO_Model_</link><description>Knight C, Howard P, Baker CL, et al. <br/><span class="title">The Cost-Effectiveness of an Extended Course (12 + 12 Weeks) of Varenicline Compared with Other Available Smoking Cessation Strategies in the United States: An Extension and Update to the BENESCO Model. [JOURNAL ARTICLE]</span><br/><span class="source" title="Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research">Value Health 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19912599/abstract/The_Cost_Effectiveness_of_an_Extended_Course__12_+_12_Weeks__of_Varenicline_Compared_with_Other_Available_Smoking_Cessation_Strategies_in_the_United_States:_An_Extension_and_Update_to_the_BENESCO_Model_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19912599/full_citation/The_Cost_Effectiveness_of_an_Extended_Course__12_+_12_Weeks__of_Varenicline_Compared_with_Other_Available_Smoking_Cessation_Strategies_in_the_United_States:_An_Extension_and_Update_to_the_BENESCO_Model_">Full Citation</a> | <a href="http://dx.doi.org/10.1111/j.1524-4733.2009.00672.x">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19912599/The_Cost_Effectiveness_of_an_Extended_Course__12_+_12_Weeks__of_Varenicline_Compared_with_Other_Available_Smoking_Cessation_Strategies_in_the_United_States:_An_Extension_and_Update_to_the_BENESCO_Model_">Find Related Articles</a> </description></item><item><title>Abuse potential of bupropion nasal insufflation: a case report.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19910738/full_citation/Abuse_potential_of_bupropion_nasal_insufflation:_a_case_report_</link><description>Langguth B, Hajak G, Landgrebe M, et al. <br/><span class="title">Abuse potential of bupropion nasal insufflation: a case report. [Letter]</span><br/><span class="source" title="Journal of clinical psychopharmacology">J Clin Psychopharmacol 2009 Dec; 29(6):618-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19910738/full_citation/Abuse_potential_of_bupropion_nasal_insufflation:_a_case_report_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0271-0749%26amp;volume=29%26amp;issue=6%26amp;spage=618">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19910738/Abuse_potential_of_bupropion_nasal_insufflation:_a_case_report_">Find Related Articles</a> </description></item><item><title>Bupropion-related parkinsonism and dystonia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19910737/full_citation/Bupropion_related_parkinsonism_and_dystonia_</link><description>Cheng WC, Liu CM, Hsieh MH, et al. <br/><span class="title">Bupropion-related parkinsonism and dystonia. [Letter, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Journal of clinical psychopharmacology">J Clin Psychopharmacol 2009 Dec; 29(6):616-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19910737/full_citation/Bupropion_related_parkinsonism_and_dystonia_">Full Citation</a></description></item><item><title>The role of dopaminergic agents in improving quality of life in major depressive disorder.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19909674/full_citation/The_role_of_dopaminergic_agents_in_improving_quality_of_life_in_major_depressive_disorder_</link><description>Ishak WW, Davis M, Jeffrey J, et al. <br/><span class="title">The role of dopaminergic agents in improving quality of life in major depressive disorder. [Journal Article]</span><br/><span class="source" title="Current psychiatry reports">Curr Psychiatry Rep 2009 Dec; 11(6):503-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19909674/abstract/The_role_of_dopaminergic_agents_in_improving_quality_of_life_in_major_depressive_disorder_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19909674/full_citation/The_role_of_dopaminergic_agents_in_improving_quality_of_life_in_major_depressive_disorder_">Full Citation</a></description></item><item><title>Varenicline in the management of smoking cessation: a single technology appraisal.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19804684/full_citation/Varenicline_in_the_management_of_smoking_cessation:_a_single_technology_appraisal_</link><description>Hind D, Tappenden P, Peters J, et al. <br/><span class="title">Varenicline in the management of smoking cessation: a single technology appraisal. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Health technology assessment (Winchester, England)">Health Technol Assess 2009 Sep.:9-13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19804684/abstract/Varenicline_in_the_management_of_smoking_cessation:_a_single_technology_appraisal_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19804684/full_citation/Varenicline_in_the_management_of_smoking_cessation:_a_single_technology_appraisal_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19804684/Varenicline_in_the_management_of_smoking_cessation:_a_single_technology_appraisal_">Find Related Articles</a> </description></item><item><title>Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19897080/full_citation/Pharmacological_and_neurotoxicological_actions_mediated_by_bupropion_and_diethylpropion_</link><description>Arias HR, Santamaría A, Ali SF <br/><span class="title">Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="International review of neurobiology">Int Rev Neurobiol 2009.:223-55.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19897080/abstract/Pharmacological_and_neurotoxicological_actions_mediated_by_bupropion_and_diethylpropion_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19897080/full_citation/Pharmacological_and_neurotoxicological_actions_mediated_by_bupropion_and_diethylpropion_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0074-7742(09)88009-4">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19897080/Pharmacological_and_neurotoxicological_actions_mediated_by_bupropion_and_diethylpropion_">Find Related Articles</a> </description></item></channel></rss>